Purpose This study was designed to evaluate performance and tissue response to a self-expandable bioabsorbable vein stent-base cut from a tube with enhanced stiffness and strength in vitro and in vivo. Methods A diamond-shaped stent-base was cut from a sequential biaxially strained poly(L-lactide) (PLLA) tube for optimized performance. The performance of the stentbase was evaluated in a finite element analysis model, and validation was attempted in vitro through a cyclic flat-plate compression and radial force measurement. The performance of the stent-base was tested in vivo using 3 sheep with 2 implants each for 2 and 3 weeks, respectively. Results In vitro the stent-base showed an elliptical deformation but no fractures. In vivo the stent-base showed adequate radial force and no migration. All implanted stent-bases showed multiple fractures not only at the predicted stress zones but at all connecting points. Fragments of the caudal stent-base stayed in the vein wall indicating sufficient tissue coverage to avoid embolization of the fractured stent pieces, whereas fragments from the cranial device remaining were few. Neointima formation was confirmed histologically at 2 and 3 weeks. Conclusion A bioabsorbable self-expandable stent-base made from PLLA for large veins seems feasible, but over time, the PLLA used in this study appears too stiff and lacks the sufficient flexibility to move with the vena cava, causing multiple fractures.
Introduction
In the case of treatment of endovascular vein diseases or prophylactic indication, permanent metal devices such as stents or inferior vena cava (IVC) filters are being used. Regardless of indication, long-term complications exist with permanent vascular devices like vessel narrowing, perforation, migration, pulmonary embolism, and reoccurring deep vein thrombosis (DVT) [1] [2] [3] which can be avoided using a temporary bioabsorbable vascular device. There are numerous studies on the bioabsorbable vascular devices for arterial use, but not for venous applications. Previous work on bioabsorbable stents focused on balloonexpandable designs with an outer diameter (OD) of 3-10 mm [4] [5] [6] [7] [8] [9] [10] [11] for arterial indications and, therefore, is not applicable for large veins [12] . Within the available bioabsorbable polymers, poly-L-Lactide (PLLA) possesses some appropriate mechanical properties and degradation rate for vascular devices. It has been widely investigated in medical applications [13, 14] . They include arterial vascular devices such as the BVS vascular stent (Abbott Vascular, Santa Clara, CA) and the Igaki-Tamai stent (Igaki Medical Planning Company, Kyoto, Japan) [9, 15] , but never as a self-expandable stent or potential stent-base for an IVC filter. Placement of a vascular self-expanding stent-base, whether functioning as a stent or as a stent-base, requires an adequate radial force to maintain its position in the lumen with no migration and must have resistance to permanent deformation [4] . The bioabsorbable elastomer polycaprolactone has been tested in vivo in the IVC as a stent-base, but due to the low stiffness of PCL, the device migrated [16] . Polydioxanone has also been tested in the IVC, which exhibited good mechanical properties for 35 days without migration, but the device was not selfexpandable [17] . It is believed that PLLA can exhibit adequate properties and may therefore be a potential candidate for a vein stent or stent-base for an IVC filter. Stentbases made from bioabsorbable polymers have inferior mechanical properties to those of metals and both radial force and resistance to a permanent deformation is low. PLLA can be induced with a greater stiffness, and provide greater resistance toward permanent deformation by straining the polymer above its glass transition temperature and thereby align its molecular chains [18] [19] [20] . The scope of this study was to evaluate the performance of a selfexpandable PLLA vein stent-base in vitro and in vivo.
Materials and Methods

Stent-Base Material and Design
A PLLA stent-base was made by sequential biaxially straining a hollow tube of PLLA 2003D (NatureWorks LLC, Minnetonka, MN) as previously described [21] and expanded from 5.5 to 10.5 mm. The tube was laser cut in a diamond-shaped pattern (8 cells circumferentially) (Fig. 1) . The stent-base with the length of 50 mm was heat treated at 63°C for 5 min after which it was further expanded over a preheated mandrill (OD 27 mm) at 93°C for 5 min. The stent-bases were sterilized with ethylene oxide at 53°C and 75% humidity for 8 h. To ensure visibility under X-ray, gold markers (1 mm in diameter) were sutured to each end of the stent-base. Through the above-mentioned processing, the stent-base becomes self-expandable. It is achieved as a combination of polymer chain orientation to improve stiffness and a tailored stent design, so that the stent-base does not undergo permanent deformation when loaded into the delivery sheath.
Cyclic Compression and Radial Force
Finite element analysis (FEA) was used to investigate stress distributions under a parallel flat-plate compression mimicking load from organs and the diaphragm on the IVC. Ultimate tensile stress (UTS) was set to 100 MPa [22] and wall thickness to 0.8 mm. Under normal conditions, the collapse index (CI) or compression degree on the IVC has been reported between 20 and 35% [23] . CI is defined by the diameter upon expiration minus the minimal diameter on inspiration divided by the diameter on expiration. For the calculation, a cava diameter of 15.0 mm was assumed with a compression to 9.8 mm, and CI was set to 35%.
For in vitro testing, the stent was placed into a silicone tube (OD 19 mm, 0.46 mm wall thickness) in water at 37°C and compressed (30%) using a moving flat plate for 150,000 cycles, corresponding to 21,600-28,800 breaths per day [24] . The radial force measurement was done in air at 37°C using an automated radial force tester from an expanded state to 6 mm at a rate of 0.5 mm/s three times.
Animal Study
Three adult sheep (1-3 years of age) were used as the animal model. Intubation anesthesia was applied using isoflurane (1-5%) (1.5-2.5 L/min). A cut down on the jugular vein was used for access, and a 16F sheath was introduced into which 100-300 IU/kg of heparin was administered. Upon loading the stent-base was crimped using a compression station, and the sheath was advanced over it, just prior to implantation. One stent-base above and one below the renal veins were implanted into the cava of each animal. Diameters of the cava were measured in right anterior (RAO) and left anterior (LAO) projection before and after stent-base implantation, respectively, and listed in Table 1 . Accurate placement and vein patency were confirmed by venography. A representative venogram of the cranial and caudal stent-bases is shown in Fig. 2 . Additional venography was performed 2 weeks after implantation. At 1 and 2 weeks post-implant, interim radiography without contrast was performed to evaluate the stent-base position. One animal was sacrificed after 2 weeks and 2 animals after 3 weeks. The cava was perfusion fixated using buffered 10% formalin solution before harvesting and examined with MRI to evaluate the integrity of the stent-bases. Tissue from lungs, spleen, and liver was investigated for residuals and fragments of the stent-bases.
Tissue Examination
Half of each explant with the stented vein was embedded in paraffin using routine techniques, cut at 5 lm, and stained with haematoxylin and eosin (H&E). The other half was used for confocal imaging. The explanted tissue was cleared to ensure greater visibility by incubating the tissue in solutions of gradually increasing fructose concentration [25] . D-(-)-fructose (JT Baker, Center Valley, PA) was dissolved in milliQ water with 0.5% a-thioglycerol (Sigma-Aldrich St. Louis, MO) at various concentrations from 20 to 115% wt/wt as described previously [26] and incubated in each solution for 12-24 h under gentle rocking.
For antibody staining, the fixed tissue was rinsed in phosphate buffered saline (PBS) blocked with 10% donkey serum in 0.2% bovine serum albumin (BSA) and permeabilized with 0.2% TritonX-100 overnight. Tissue was incubated with a primary antibody against fibrinogen (ab 119948 1:100, Abcam), diluted in 0.2% BSA and PBS, for 2 days at 4°C then rinsed 3 9 30 min. Samples were next stained with secondary labeling reagents for nuclei (DAPI, 1:500, LifeTechnologies), actin filaments (AF488 conjugated phalloidin 1:100, LifeTechnologies), and antimouse secondary antibody (AF555-conjugated 1:500, LifeTechnologies) for 2 days at 4°C, and then rinsed 3 9 30 min and stored at 4°C until imaged.
To increase the optical resolution and the contrast of the probe, a spatial pinhole was placed at the confocal plane of the lens to eliminate out-of-focus light. Tissue samples were imaged with an inverted confocal laser microscope (710 LMS, Zeiss, Germany) with laser wavelengths from 405 to 639 nm. Images were obtained as 1024 9 1024 pixels with ZEN 2011 software and taken as a best compromise between overlaid laser wavelengths.
Results
Radial Force and Fatigue Testing
The radial force was highest after the first crimp and reduced slightly during the second and third crimps (Fig. 3) . The stent-base in the physiological procedure would be crimped into the loading sheath (16F) and selfexpand into the vessel of a given size. In the in vivo study, the average diameter was approximately 15-16 mm and the stent-base would, therefore, exert a radial force of approx. 2.8 N on the vessel.
The fatigue performance of the stent-base was evaluated by a flat-plate crush analysis, both theoretically by finite element analysis (FEA) and in vitro. The FEA results (Fig. 4) show that the critical fatigue locations are found at the connection points on the side of the stent-base during compression. The critical fatigue locations in the red zone would be expected to fracture first, if physiological loading exceeds the capabilities of the newly-deployed stent. Neither crimping nor flat-plate compression in vitro demonstrated a fracture of the stent-base.
During crimping in the in vivo study, the stent-base was permanently deformed from 28 to 24 mm after being circumferentially compressed into a 16F sheath while Step 1 Circumferential crimping Delivery sheath n = 2 28.1 ± 0.6 24.6 ± 0.4 24.6 ± 0.4 Circular
Step 2 Flat-plate compression Wet at 37°C n = 1 24.2 20.4
Elliptical
Additionally diameter before stent base was delivered into a silicon tube and after cyclic flat-plate compression under physiological conditions at 37°C (step 2). n is the number stent-bases tested. OD top is the distance from top to bottom which was in contact with the flat-plate, and OD side is the distance from one side to another not in contact with the flat-plate maintaining its circular shape (Table 2) . During cyclic compression in vitro, the stent-base deformed permanently from circular to elliptical. This is due to the fact that water or physiological fluids acts as a plasticizer and ultimately makes the polymer stent-base softer and more susceptible to a permanent set [27] .
Imaging
The gold markers were at the same location in all animals after implantation, at 1 week and after 2 weeks. The position of the gold markers confirmed a stable position of the stent-base without migration. Venography confirmed patency after 2 weeks (1 animal). The vena cava diameter was smaller than that before implantation and was likely due to different positioning of the animal and could not be used to determine the integrity of the device. MRI images of explants after 2 weeks illustrated numerous fractures which were visually confirmed by light microscopy. A representative section of the vein had 13 fractures (see 5B ) after 3 weeks. The fractures occurred at the connection points and between cells adherent to each other. The cranial devices at both time points were minimally intact, and only a few pieces remained at the site of implantation, whereas the fractured caudal devices remained in the vessel. Necropsy of lung tissue did not reveal end location of the migrated pieces.
Histology
After 2 and 3 weeks, the struts were closely apposed to the lumen surface and were covered by neointima with a thickness of 20-100 lm and 100-300 lm, respectively (Fig. 6) . The neointima was composed of loosely arranged spindle-shaped cells and fibrovascular tissue with some fibrin. At 2 weeks, some struts were covered with a singlecell layer of endothelium, and after 3 weeks, most struts were covered with neointima and endothelium. At both time points, inflammation was minimal and composed of a few macrophages immediately adjacent the struts and few lymphocytes in the adjacent neointima. At the attachment sites between struts, vein wall smooth muscle cells were minimally vacuolated, suggesting mild focal pressure change.
Confocal Imaging
Confocal imaging was used to visualize the newly formed tissue around the connection points without disrupting the tissue. It has the advantages of visualizing both the strut surface facing the lumen and the sides of the strut covered with neointima. The images showed cellular ingrowth around and in the connection points by either neointima nuclei (blue) or actin filament (green) (Fig. 7) . Fibrinogen (red) covers both the struts in (Fig. 7A, B ) and connection (Fig. 7C) . The neointima around a strut that has fractured at the connection point measured between 70 lm (top of the strut) and 120 lm (on the right side) (Fig. 7A) . The actin filaments occur only in the top cell layer (40-66 lm) on the sides and are aligned along the strut. At the fracture tip of the strut, the actin-filaments are randomly oriented.
Discussion
One of the major concerns regarding a bioabsorbable polymeric device is the risk of migration and loss of integrity. It was hypothesized that a stent-base can be made from PLLA tubing, which had undergone a straining process. The stentbases were successfully crimped and delivered into the vena cava with no migration upon implantation or after 3 weeks. The radial force of 2.8 N was adequate to prevent migration. The overall inflammation response to the PLLA stent-base was minimal. Both H&E and confocal imaging showed fewer smooth muscle cells in the vein wall under the stent-base suggesting a mild focal fibrosis due to the oversized stent-base and resultant focal compression. In comparison, the Gianturco stainless steel stent (OD 24 mm and length 55 mm), which has been used for treatment of superior vena cava syndrome [28] , showed a radial force of approximately 2 N when crimped 37.5% [29] . The compression degree was extrapolated to match the average size of the vena cava in this study. Therefore, it could be possible to place the PLLA stent-base in the vein for the same indications as the Gianturco stent. Furthermore, when placed in vena cavas with a 10% smaller diameter than the stent [30] , the neointima growth was 200 lm at week 4 and in the same range as what observed for the PLLA stent-base. The tissue response of an over-expanded vein to the PLLA stent-base is similar to one of stainless steels, despite the larger degree of over-expansion in this study. Both caudal and cranial stent-bases fractured to the same degree in all three animals, but little remained of the cranial devices. Their end location was not revealed through necropsy indicating that the pieces were too small to detect. It is believed that the caudal stent-base was not exposed to the same degree of stress or that tissue coverage occurred faster over the caudal device before fractures occurred. Necropsy showed that above the renals, the liver and other viscera were more compacted into the cranial abdomen, and along with diaphragm movements, the cranial device was exposed to compression from multiple sides.
Although in vitro tests did not visually reveal any fracture of the stent-base, MRI and light microscopy confirmed that multiple fractures occurred at those sites where FEA was predicted to be critical. With fractures, the stentbase lost its integrity and would not be as stressed in the same manner, and no additional fractures were expected. The stent-base continued to fracture circumferentially at every connection point. The fragments of the caudal device did not migrate, and fractures likely occurred after tissue coverage adequately covered the stent-base.
PLLA is a brittle polymer and this particular stent-base is not flexible enough to move with the vena when the connection points are covered in tissue, leading to multiple device fractures. For a stent-base to successfully survive cyclic compression, it would have to be made more flexible, but still induce enough radial force to avoid migration. If the stent-base should function as a stent-base in an IVC filter, the filtration cone could either be done by applying bioabsorbable connected sutures to the top of the stent-base as done by Zhang et al. [16] or they could be laser-cut to extend from the stent-base.
Conclusion
Bioabsorbable self-expandable stent-bases made from PLLA tube were successfully delivered in an ovine vena cava. The tissue response and radial force were found adequate to prevent device migration. After two weeks, the explants had multiple circumferential fractures in the specific locations predicted by the FEA. The tissue response did not cause vessel narrowing and was sufficient to lock the stent in place. This particular PLLA stent-base did not have the flexibility to move with the vessel after tissue coverage. The locked circumferential stent-base cells fractured, resulting in stent-base failure.
